SGK
IMNN icon

Steigerwald Gordon & Koch’s Imunon IMNN Stock Holding History

Steigerwald Gordon & Koch’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2 Hold
1
– – ﹤0.01% 764
2026
Q1 		$3 Hold
1
– – ﹤0.01% 777
2025
Q4 		$4 Hold
1
– – ﹤0.01% 913
2025
Q3 		$5 Buy
+1
New +$7 ﹤0.01% 812

Other funds holding IMNN

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RCA
Riverview Capital Advisers Boston, Massachusetts $349M AUM 33.11% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Steigerwald Gordon & Koch's IMNN Position: Q2 2026 in Review

Steigerwald Gordon & Koch held its Imunon (IMNN) position steady in Q2 2026 at 1 share worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #764.

Steigerwald Gordon & Koch first reported a position in IMNN in Q3 2025 and has held it in 4 quarters since. The position peaked at $5 in Q3 2025. 23 funds tracked by Wall St. Rank hold IMNN as of Q2 2026.

  • Steigerwald Gordon & Koch held 1 share of Imunon worth $2 as of Q2 2026.
  • Steigerwald Gordon & Koch left its Imunon share count unchanged in Q2 2026.
  • Imunon made up ﹤0.01% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #764 holding.
  • Steigerwald Gordon & Koch first reported a position in Imunon in Q3 2025 and has held it in 4 quarters since.
  • Steigerwald Gordon & Koch's Imunon position peaked at $5 in Q3 2025.
  • 23 funds tracked by Wall St. Rank held Imunon as of Q2 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.